Please login to the form below

chronic diseases

This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.

Bayer's drop of the future

obviously, one of the world’s most important chronic diseases. ... And it hasn’t stopped there. It’s extended the same idea to hyperlipidaemia and hypertension, the two other big chronic conditions whose populations overlap.

Latest news

Moderna completes enrolment of phase 3 COVID-19 vaccine trial

On top of that, over 8, 000 participants are living with chronic diseases and 22% are healthcare workers.
Bayer signs €250m pact with India’s Curadev for STING drugs

started working on STING drugs with potential in auto-immune and inflammatory diseases. ... Excessive signalling through cGAS–STING has been linked to a range of chronic and rare diseases, including neurodegenerative conditions like Parkinson’s,
Pfizer eyes 20-strain Prevnar filing this year, after phase 3 win

Pneumococcal disease is caused by Streptococcus pneumoniae, and includes non-invasive illnesses like pneumonia, sinusitis and middle ear infections, as well as invasive diseases like meningitis. ... The most vulnerable populations are children under the
US start-up EQRx promises approach that will slash drug prices

to its launch statement, which says it will focus on “life threatening and chronic diseases”.
How AI is transforming the way we collect market insights

For patients, particularly those with chronic diseases, AI can help them to become much more compliant.

More from news
Approximately 2 fully matching, plus 177 partially matching documents found.

Latest Intelligence

Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?

Much of this growth is being driven by the urgent need to innovate in chronic diseases such as cancer, diabetes, mental illness, heart disease and respiratory disease. ... Approximately half of all adults worldwide today are living with a chronic
The US celebrates five years of biosimilars on the market – a look to the past, present and future

chronic diseases such as rheumatoid arthritis. ... As these medicines become more commonplace, and as the US population continues to age and face rising rates of chronic disease, the associated costs will likely continue to rise.
Power to the patient: digital innovation supporting patients with chronic diseases

While these new and revamped assets are crucial in managing patient care, digital channels have long been utilised to directly engage and support those living with chronic diseases.
What Hemingway got right about patient communications

Smartphone apps for chronic diseases. Over the last two years, we (Teva UK and Ireland and 11 London) have been building comprehensive smartphone apps that help people with chronic diseases, such
On our best behaviour

Why driving behaviour change is the next big focus for pharma companies in chronic diseases. ... The main disease areas of focus have understandably been chronic diseases, including obesity, diabetes, cardiovascular disease (CVD) and chronic obstructive

More from intelligence
Approximately 2 fully matching, plus 56 partially matching documents found.

Latest appointments

Kymab appoints its first chief medical officer

She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
Dr Li Zhou joins TxCell as cell engineering VP

Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
Sanofi’s US pharma head joins Synta as CEO

She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.
Medgenics confirms appointment of Dr Marvin Garovoy

The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

October 2020: diversity and inclusion in clinical trials round-up

In the U.S., these chronic conditions disproportionately affect minority populations, meaning minorities entered the pandemic with health disparities that put them at a disadvantage. ... In the U.S., fewer healthcare providers have training, knowledge,
In the precision medicine era, the line between products and services is blurred

This has gained a lot of attention in recent years due to revolutionary breakthroughs in debilitating chronic diseases such as cancer.
Changing and Sustaining Lifestyle Habits with Digital Therapeutics

used to inspire people at risk of developing chronic diseases to achieve and sustain, healthier lifestyles.
Interactive infographic

Living With: The journey from the patient’s perspective. Research Partnership's new interactive infographic reveals insights into the patient journey across a range of chronic diseases.
Digital therapeutics and their impact on society

This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma. ... To solve this problem, our systems must be more efficient and more

More from PMHub
Approximately 4 fully matching, plus 28 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Account Director: Competitive

Medical Editor: Competitive

Healthcare Lead Copywriter: Competitive

Healthcare Senior Account Manager: Competitive

Senior Leader: Exceptionally competitive salary

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...